In the 1980s, gram-positive organisms, including Staphylococcus aureus, reemerged as the leading causes of nosocomial bacteremia [1, 2] . From 1980 to 1989, the National Nosocomial Infections Surveillance System (NNIS) of the Centers for Disease Control and Prevention (CDC) reported increases in the rates of primary bacteremia due to S. aureus of 122% to 283% [1] . During the late 1980s, S. aureus caused 16% of nosocomial bacteremias reported to the NNIS, second only to coagulasenegative staphylococci [3] . An increase in the rate of S. aureus bacteremias also has been observed abroad. In Denmark, the annual incidence rate of S. aureus bacteremia increased from 2.7 cases per 100,000 population in 1960 to 19.2 cases per 100,000 population in 1990, with nosocomial bacteremias accounting for most of this increase [4] .
See the editorial by Darouiche and Musher on pages 260-1.
A larger population of immunocompromised individuals and increased use of intravascular devices are among the factors causing this resurgence of staphylococcal bacteremias. In addition, the emergence of methicillin-resistant S. aureus (MRSA) contributes to the upward trend in S. aureus infections. Changes in community-acquired S. aureus bacteremia are less well char-acterized. The objectives of this study are to describe trends in nosocomial and community-acquired S. aureus bacteremias since 1980 and to examine risk factors for S. aureus bacteremia including the impact of intravascular devices.
Methods
Crawford Long Hospital of Emory University is a 500-bed acute care hospital in downtown Atlanta. Community-based physicians and full-time university faculty utilize the facility, which serves as both a community hospital and a referral center.
All bloodstream infections were identified by the infection control department as part of routine surveillance. For this study, we compared bloodstream infections due to S. aureus during 1980-1983 with those during 1990-1993. Clinical information, including the presence of underlying diseases and source of bacteremia, was obtained by chart review. Nosocomial bacteremia was defined by a bloodstream isolate obtained -48 hours after hospital admission, while community-acquired bacteremia was defined by a bloodstream isolate obtained within 48 hours of hospital admission. However, blood isolates obtained within 48 hours of readmission were classified as nosocomial if the infection was determined by the infection control practitioner to be incubating at the time of a recent (<30 days) hospital discharge.
Blood isolates of S. aureus were considered to be contaminants if only one blood culture set yielded the organisms, if the clinicians judged the organisms to be contaminants, and if antibiotic therapy directed against the organisms was not administered.
Intravascular device-related S. aureus bacteremia was defined as bacteremia unrelated to infection at an extravascular site with semiquantitative culture of a catheter tip yielding > 15 colonies or with infection at a local catheter site that was due to the same organism. When the catheter was not removed or the tip was not cultured, the infection was considered to be device-related if the infection control practitioner, the hospital epidemiologist, or the involved clinicians determined a device to be the likely source. During the 1980-1983 study period, the hospital microbiology laboratory used the BACTEC 460 radiometric system (Becton Dickinson, Sparks, MD); for each set of blood cultures, a 7.5-to 10-mL blood sample was inoculated into aerobic, anaerobic, and hypertonic media. During the 1990-1993 study period, the BACTEC 660 nonradiometric system (Becton Dickinson) was used; a blood sample of 20 mL was inoculated into aerobic and anaerobic vials.
During both study periods, the hospital's policy called for replacement of peripheral intravenous catheters after 72 hours. There was no similar standard governing the duration of the placement of central venous catheters. From 1980-1983, there was limited use of central venous catheters outside of the intensive care units, and implanted ports and tunneled cuffed catheters were either not commercially available or not used.
The Mantel-Haenszel X2 test was used to determine statistical significance.
Results
The rate of bacteremia doubled during the second 4-year period, with the rate of nosocomial bacteremia increasing from 4.59 to 9.44 cases per 1,000 discharges and the rate of community-acquired bacteremia increasing from 6.2 to 13.46 per 1,000 discharges (figure 1). The rates of nosocomial and communityacquired S. aureus bacteremias also increased from 0.75 to 2.80 cases per 1,000 discharges and from 0.84 to 2.43 cases per 1,000 discharges, respectively. Table 1 shows the numbers of S. aureus and other bacteremias for the study periods. The proportion of nosocomial bacteremia caused by S. aureus increased from 16.3% to 29.6% (P < .001), and the proportion of community-acquired bacteremia caused by S. aureus increased from 13.5% to 18.1% (P < .05). The annual average number of blood cultures performed also doubled from 7,758 to 15,725, while the annual number of hospital discharges decreased slightly from 22,117 to 20,540 over the same periods. Two S. aureus isolates (1.4%) recovered from blood cultures were considered contaminants during the first period compared with 14 (3.1%) during the second period. (nine due to MRSA) were from infected decubitus ulcers in nursing home patients, and 11 were from lower extremity infections in patients with diabetes or vascular insufficiency. Bacteremias related to hemodialysis shunts and fistulas were common in both study periods.
Two patients with community-acquired bacteremia in the 1980-1983 period and four patients in the 1990-1993 period were intravenous drug users. Comparing 1990-1993 with 1980-1983, nursing home residence (16% vs. 4%, respectively), AIDS (10% vs. 0, respectively), and sickle cell anemia (8% vs. 0, respectively) were significantly (P < .05) more common, whereas diabetes (27% vs. 22%, respectively), renal failure (28% vs. 35%, respectively), and cancer (9% vs. 16%, respectively) were not. The mean age of patients with community-acquired bacteremia was 55 years in the 1980-1983 period and 57.6 years in the 1990-1993 period. Although nursing home residence was more common in the 1990-1993 period, a greater percentage of patients were 65 years of age or older in the earlier period (45% vs. 39%, respectively). Sixty-five percent of patients with community-acquired S. aureus bacter- emia during the second study period were hospitalized within 1 year before the bacteremia, and 52% were hospitalized within 90 days of the bacteremia.
Types of Intravascular Devices
The types of intravascular devices associated with S. aureus bloodstream infections are listed in table 3. From 1990 to 1993, central venous catheters and peripheral intravascular catheters were associated with 31% and 18%, respectively, of the nosocomial device-related infections. These bacteremias occurred in patients with a wide variety of underlying medical and surgical problems. Implanted ports were the source of 25% of the nosocomial bacteremias; 18 (56%) of the port-related infections occurred in patients with sickle cell disease, and 12 (38%) occurred in oncology patients. The 18 bacteremias in patients with sickle cell disease occurred in 12 patients. Six patients each had two bacteremias associated with implanted ports; the same device was implicated as the source in three of these six patients. Underlying diseases in patients with community-acquired MRSA bacteremia included diabetes (29%), chronic renal failure (23%), cancer (14%), AIDS (9%), and sickle cell anemia (3%). Nursing home residence, but not any of these underlying diseases, was associated with a significantly higher risk of MRSA infection (P < .001). The mean age of patients with community-acquired MRSA bacteremia was 67.7 years; 58% were 65 years of age or older. Intravascular devices, implicated in no community-acquired bacteremias during the first study period, were associated with 22% of community-acquired S. aureus bacteremias from 1990 to 1993. We believe that this increase likely reflects the shifting of acute medical care to the outpatient setting and the increasing use of long-term devices in patients with chronic disorders, such as AIDS, cancer, and sickle cell disease. Although outpatient infusion therapy has been associated with a low rate of infectious complications [6] , given current economic pressures, this low rate is likely to apply to an increasing population. In addition, the low reported rate of infections may not apply to all populations. Thus, a further increase in the total number of cases of community-acquired device-related infections may occur.
Sources of community-acquired device-related bacteremias during 1990-1993 included implanted ports (49%), hemodialysis catheters (33%), tunneled cuffed catheters (9%), and peripheral intravenous catheters (5%)
.
Discussion
MRSA was responsible for 32% of nosocomial S. aureus bacteremias during the 1990-1993 period, a proportion consistent with NNIS data for hospitals of comparable size [7] . MRSA also caused 18.5% of community-acquired S. aureus bacteremias from 1990 to 1993. Most of these infections occurred in patients who had been hospitalized recently or were nursing home residents, and all patients with communityacquired MRSA bacteremia had regular contact with health care settings.
Our definition of nosocomial infection was adapted from definitions of the CDC that were designed for the NNIS hospitals [8] ; all other infections were termed community-acquired. For patients with chronic medical illnesses who may require periodic hospitalizations, home health care, and, possibly, outpatient parenteral therapy, the term community-acquired is misleading. These patients are at greater risk for serious infections, including those caused by antibiotic-resistant microorganisms such as MRSA, than are those without prior contact with health care facilities. For example, approximately two of three patients admitted to our hospital with community-acquired bacteremia due to S. aureus (methicillin-susceptible S. aureus or MRSA) had been hospitalized within the previous year.
The term nosohusial has been suggested to describe infections occurring in patients who receive care at home [6] . Whether this new term finds widespread acceptance, the distinction between patients requiring frequent contact with health care settings and those whose infections are truly communityacquired is valid. The increase in the number of patients receiving care at home emphasizes the need to develop methods for studying infections occurring in this setting. Although useful information can be obtained from hospital-based surveillance, an accurate determination of infection rates occurring in nonhospital settings should utilize the population at risk as the denominator. In addition, the use of multiple commercial clinical laboratories for performing culture and sensitivity testing further complicates attempts to determine infection rates in the nonhospital setting. Thus, further home care-based studies are warranted.
These data show a significant increase in the number of intravascular device-associated bacteremias since 1980. Because of the design of this study, we were unable to measure device utilization or establish infection rates associated with various types of devices. However, the increased use of intravascular devices, particularly central venous catheters, has been implicated in the increased rates of septicemia from 1979 to 1987 that were recorded by the National Hospital Discharge Survey [9] . Fifty-six percent of nosocomial bacteremias in the second study period were device-related, a figure consistent with those of other published series [10] . Fifty-two percent of the nosocomial device-associated infections during the second study period were confirmed by cultures of catheter tips or specimens from device sites that yielded S. aureus. A more rigorous definition of device-associated infection, such as requiring cultures of catheter tips or specimens from device sites, could have led to a significant underestimation of the impact of devices. We believe that it is more likely that some of the bacteremias termed as unknown were device-related and that our calculation of device-associated infections is conservative.
A surprising finding in our study was the high number of nosocomial and community-acquired port-related bacteremias. Implanted ports have been associated with a low incidence of infection (range, 0.01-0.04 bloodstream infections per 100 device-days [11, 12] ). Our data reflect, in part, a large population of patients with diseases such as sickle cell anemia and AIDS and a high utilization of implanted ports in these patients. In addition, suboptimal care of the devices and patient use of ports for injection of illicit drugs were suspected in a few instances. Although we were unable to determine rates of portrelated bacteremia, our experience raises concern that the reported incidence of port-related infections may not apply to all settings. Notwithstanding the inferences about rates of portrelated infection, these data demonstrate how the use of implanted ports can change the epidemiology of bloodstream infections.
The overall increase in the rates of bacteremia may be confounded by changes in blood culturing methodology and an increase in the number of blood cultures performed. During the 1990-1993 study period, the standard blood specimen for a set of blood cultures was 20 mL, twice that obtained in the 1980-1983 period. A recent controlled trial demonstrated that increasing the volume of blood inoculated into a culture vial from 2.7 mL to 8.7 mL increased the yield of gram-positive pathogens by 19% [13] . The number of blood cultures performed per year doubled from the first to the second study period. This pattern of increased utilization of blood cultures during the 1980s has been reported by other researchers and has been attributed to the presence of a sicker patient population [14] .
The annual number of bacteremias also doubled in the second study period, resulting in a stable rate of blood culture positivity. This finding suggests that the methodological changes were not the major cause of the increased rates of bacteremia during 1990-1993. It is also unlikely that these factors accounted for the disproportionate increases in the numbers of S. aureus and device-related bacteremias.
In summary, these data show parallel increases in rates of nosocomial and community-acquired S. aureus bacteremias since 1980. Device-related infection, the leading source of nosocomial S. aureus bacteremia, is emerging as an important source of community-acquired bacteremia in our hospital. Similarly, MRSA bacteremia, once confined to the nosocomial setting, is an increasing problem in the nonhospital setting. The shifting of care, including parenteral therapy, to the outpatient setting likely accounts for some of these observations.
